180 related articles for article (PubMed ID: 25114902)
21. The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
Gregersen H; Vangsted AJ; Abildgaard N; Andersen NF; Pedersen RS; Frølund UC; Helleberg C; Broch B; Pedersen PT; Gimsing P; Klausen TW
Cancer Med; 2017 Jul; 6(7):1807-1816. PubMed ID: 28639741
[TBL] [Abstract][Full Text] [Related]
22. Impact of the Charlson comorbidity index and prognostic nutritional index on prognosis in patients with early gastric cancer after endoscopic submucosal dissection.
Iwai N; Dohi O; Naito Y; Inada Y; Fukui A; Takayama S; Ogita K; Terasaki K; Nakano T; Ueda T; Okayama T; Yoshida N; Katada K; Kamada K; Uchiyama K; Ishikawa T; Handa O; Takagi T; Konishi H; Yagi N; Itoh Y
Dig Endosc; 2018 Sep; 30(5):616-623. PubMed ID: 29532961
[TBL] [Abstract][Full Text] [Related]
23. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
24. Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older.
Cai X; Wu H; Peng J; Zhu J; Cai S; Cai G; Zhang Z
Radiat Oncol; 2013 Apr; 8():86. PubMed ID: 23574985
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome.
Trakada G; Kastritis E; Gavriatopoulou M; Velentza L; Fotiou D; Ziogas DC; Panagiotidis I; Eleutherakis-Papaiakovou E; Roussou M; Migkou M; Kanellias N; Ntanasis-Stathopoulos I; Kallianos A; Terpos E; Dimopoulos MA
Ann Hematol; 2019 Jun; 98(6):1427-1434. PubMed ID: 30834954
[TBL] [Abstract][Full Text] [Related]
27. N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma.
Milani P; Vincent Rajkumar S; Merlini G; Kumar S; Gertz MA; Palladini G; Lacy MQ; Buadi FK; Hayman SR; Leung N; Dingli D; Lust JA; Lin Y; Kapoor P; Go RS; Hwa YL; Gonsalves WI; Zeldenrust SR; Kyle RA; Dispenzieri A
Am J Hematol; 2016 Nov; 91(11):1129-1134. PubMed ID: 27508522
[TBL] [Abstract][Full Text] [Related]
28. Real-World Clinical Outcomes in Elderly Chinese Patients with Multiple Myeloma: A Single-Center Experience.
Qian X; Chen H; Xia J; Wang J; Zhou X; Guo H
Med Sci Monit; 2018 Aug; 24():5887-5893. PubMed ID: 30138301
[TBL] [Abstract][Full Text] [Related]
29. The effect of comorbidity on the prognosis of acute lung injury and acute respiratory distress syndrome.
Ando K; Doi T; Moody SY; Ohkuni Y; Sato S; Kaneko N
Intern Med; 2012; 51(14):1835-40. PubMed ID: 22821096
[TBL] [Abstract][Full Text] [Related]
30. Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients.
Djebbari F; Sharpley FA; McLain-Smith S; Vallance G; Eyre TA; Kothari J; Moore S; Ramasamy K
PLoS One; 2020; 15(2):e0229469. PubMed ID: 32084254
[TBL] [Abstract][Full Text] [Related]
31. Outcome of older myeloma patients in relationship to comorbidities and availability of second-generation novel agents in a real-life setting.
Lalive d'Epinay M; Güsewell S; Graf N; Mey UJM; Driessen C; Hitz F
Hematol Oncol; 2022 Oct; 40(4):716-723. PubMed ID: 35574642
[TBL] [Abstract][Full Text] [Related]
32. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
[TBL] [Abstract][Full Text] [Related]
33. The application of the Palliative Prognostic Index, charlson comorbidity index, and Glasgow Prognostic Score in predicting the life expectancy of patients with hematologic malignancies under palliative care.
Chou WC; Kao CY; Wang PN; Chang H; Wang HM; Chang PH; Yeh KY; Hung YS
BMC Palliat Care; 2015 Apr; 14():18. PubMed ID: 25924723
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patients.
Rampotas A; Djebbari F; Panitsas F; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Lim WY; Eyre TA; Moore S; Ramasamy K; Kothari J
Eur J Haematol; 2021 Apr; 106(4):563-573. PubMed ID: 33496996
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Comorbidity Indices for a Study of Patient Outcomes Following Cervical Decompression Surgery: A Retrospective Cohort Study.
Oichi T; Oshima Y; Takeshita K; Chikuda H; Tanaka S
Spine (Phila Pa 1976); 2015 Dec; 40(24):1941-7. PubMed ID: 26655806
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
[TBL] [Abstract][Full Text] [Related]
37. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
[TBL] [Abstract][Full Text] [Related]
38. Comorbidities in multiple myeloma and implications on survival: A population-based study.
Sverrisdóttir IS; Rögnvaldsson S; Thorsteinsdottir S; Gíslason GK; Aspelund T; Turesson I; Björkholm M; Gregersen H; Hveding Blimark C; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Jun; 106(6):774-782. PubMed ID: 33565126
[TBL] [Abstract][Full Text] [Related]
39. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification.
Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1131-7. PubMed ID: 25577223
[TBL] [Abstract][Full Text] [Related]
40. Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma.
Song GY; Jung SH; Kim K; Kim SJ; Yoon SE; Lee HS; Kim M; Ahn SY; Ahn JS; Yang DH; Kim HJ; Lee JJ
BMC Cancer; 2020 Aug; 20(1):803. PubMed ID: 32831058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
